Research of the State University of New York at Buffalo has shown that the treatment of osteoporosis can prevent gum disease. His findings were published in the July issue of the journal «Menopause: The Journal of the North American Menopause Society».
The researchers analyzed the prevalence of periodontal disease in women during menopause. They found that participants older than 50 years treated with estrogen for the treatment of osteoporosis, were 44% less likely to develop periodontal disease, compared to participants in the control group.
The lack of sex hormones, typical of menopause, increases the risk of osteoporosis in the fairer sex. To protect against the disease, some women are prescribed estrogen therapy and recommend taking calcium supplements and vitamin D.
Previously, scientists have studied the relationship between osteoporosis and tooth loss, but few have examined the association between estrogen therapy and periodontitis - a disease that can lead to tooth loss and the destruction of the jawbone.
In the current study involved about 500 women in menopause. In 356 participants were diagnosed with osteoporosis, and 113 of them have decided to undergo estrogen therapy.
All the women were older than 50 years, they were in menopause for at least a year. They were divided into two groups. The first group took estrogen terpenes at least 6 months, and the second did not receive treatment.
They found that women who received treatment had better indicators of periodontal probing and a lower level of clinical attachment loss. They have less bleeding gums.
The study also found that higher income and frequent dental visits were associated with decreased prevalence of periodontitis.
While estrogen plays an important role in maintaining bone health, hormone therapy can cause side effects: increased risk of cardiovascular disease and breast cancer .
Further research is needed to understand whether the prevention and treatment of osteoporosis can help control periodontitis and tooth loss.